Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Shareholder Equity 2009–2025
Cyclacel Pharmaceuticals, Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cyclacel Pharmaceuticals, Inc. shareholder equity for the quarter ending December 31, 2025 were 6.8M, a 414.72% decrease year-over-year.
- Cyclacel Pharmaceuticals, Inc. shareholder equity for 2025 were 6.8M, a 414.72% decrease from 2024.
- Cyclacel Pharmaceuticals, Inc. shareholder equity for 2024 were -2.2M, a 458.15% decrease from 2023.
- Cyclacel Pharmaceuticals, Inc. shareholder equity for 2023 were 607,000, a 96.19% decrease from 2022.
- Cyclacel Pharmaceuticals, Inc. shareholder equity for 2022 were 15.9M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cyclacel Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $-2 |
| 2023 | $1 |
| 2022 | $16 |
| 2021 | $38 |
| 2020 | $33 |
| 2018 | $15 |
| 2017 | $22 |
| 2016 | $14 |
| 2015 | $19 |
| 2014 | $22 |
| 2013 | $28 |
| 2012 | $10 |
| 2011 | $20 |
| 2010 | $25 |
| Cyclacel Pharmaceuticals, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $7 |
| 2024-12-31 | $-2 |
| 2023-12-31 | $1 |
| 2022-12-31 | $16 |
| 2021-12-31 | $38 |
| 2020-12-31 | $33 |
| 2018-12-31 | $15 |
| 2017-12-31 | $22 |
| 2016-12-31 | $14 |
| 2015-12-31 | $19 |
| 2014-12-31 | $22 |
| 2013-12-31 | $28 |
| 2012-12-31 | $10 |
| 2011-12-31 | $20 |
| 2010-12-31 | $25 |
Cyclacel Pharmaceuticals, Inc. Shareholder Equity — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) shareholder equity over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGMS's shareholder equity history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.